Atlas Trials

First Line Metastatic Breast Cancer Treatment (ESMERALDA)

Clinical trial NCT01941407 · COMPLETED

Trial details

NCT number
NCT01941407
Sponsor
ARCAGY/ GINECO GROUP
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2013-11-01
Primary completion
2014-08-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.